Pennon returns to profit after water bill hikes
Anteris Advances Global PARADIGM Expansion with French Regulatory Clearance
Anteris Appoints Susan Knight and Stephen Denaro to its Board of Directors
Anteris adds Susan Knight, Stephen Denaro to board as company advances heart valve strategy
Anteris advances PARADIGM trial as Q1 cash burn reflects commercialisation push
Anteris Announces Results for the First Quarter of 2026
Anteris Announces Results for the First Quarter of 2026
Whirlpool cuts forecast, suspends dividend as Iran war hammers demand
Dow Jones set for flat start as market await Iran response to US peace deal
JD Sports preview: signs of recovery in focus ahead of World Cup
Voyager Technologies narrows loss in Q1 as revenue comes in below expectations
Nasdaq and S&P surge to new records on Iran deal hopes, AMD and Disney gains
Small Cap Watch: Small Ordinaries edges higher as company news flow continues
Anteris treats first US patients in DurAVR pivotal trial
Anteris Technologies Announces First U.S. Patients Treated in Global Pivotal PARADIGM Trial
Anteris Technologies Secures CMS Reimbursement Supporting U.S. Site Activation for PARADIGM Trial
Anteris Technologies Global Corp. (NASDAQ:AVR) Short Interest Update
Reviewing Anteris Technologies Global (NASDAQ:AVR) and Glaukos (NYSE:GKOS)
A new valve, a new playbook: How Anteris is trying to reshape a $10B heart market
Tilray Brands’ strong cannabis sales and upbeat outlook keeps Jefferies analysts bullish
GLP-1 wars: Lilly's FDA-approved oral weight-loss pill puts Novo Nordisk's Wegovy franchise under fresh pressure
Smart automation bots and the future of forex trading
Anteris Technologies Global CEO Touts DurAVR Redesign, Durability Claims and TAVR Market Strategy
Melrose shares drop 12% as guidance disappoints despite strong cash flow beat
Anteris reports US$77.8m 2025 net operating cash outflow as PARADIGM trial gets underway
Anteris Reports 2025 Financial Results and Provides Corporate Update
Analyzing Anteris Technologies Global (NASDAQ:AVR) and Elekta (OTCMKTS:EKTAY)
Anteris Technologies Global Corp. (NASDAQ:AVR) Sees Significant Increase in Short Interest
Anteris Announces Strategic Investment from Medtronic to Continue Advancing TAVR in $320 Million Aggregate Capital Raises
Anteris Technologies Global Corp. Announces Closing of $230 Million Public Offering of Common Stock
Anteris flags proposed US$200 million raising, Medtronic commits up to US$90 million strategic investment
What Sparked Anteris Technologies (AVR) Stock Surge Over 52% After-Hours?
Anteris Technologies Global Corp. Announces Pricing of $200 Million Public Offering
Anteris unveils strong 30-day DurAVR® data in 100-patient small-annulus cohort
Amazon returns to US bond market with $12B offering
Anteris Technologies Presents Data from 100 DurAVR® THV Patients at PCR London Valves
Anteris Announces Results for the Third Quarter of 2025
Anteris Technologies Announces First Patients Treated in DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)
Anteris Technologies Announces One-Year Clinical Outcomes for DurAVR® THV to be Presented at TCT® 2025
Anteris secures first European green light to start PARADIGM pivotal trial of DurAVR THV
Anteris Technologies Global Corp. Announces Adjournment of Special Meeting of Stockholders
Anteris Technologies Global Corp. Announces Postponement of Special Meeting of Stockholders
Anteris Technologies Global Corp. Announces Postponement of Special Meeting of Stockholders
Anteris Announces Results for the Second Quarter of 2025
Anteris Appoints David Roberts and Gregory Moss to its Board of Directors
Anteris Technologies prepares for US initial public offering with Registration Statement
Anteris Technologies and v2vmedtech Announce Concept Lock of Next Generation Mitral and Tricuspid Repair System as VClip™ Passes Animal Study
Anteris Technologies Announces Presentation of First-In-Human Data for its Novel TAVR Product, DurAVR™ at the 2022 Annual TCT Congress in Boston